Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus II Infection”

228 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 228 results

Testing effectiveness (Phase 2)Study completedNCT00000940
What this trial is testing

Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 121
Testing effectiveness (Phase 2)Study completedNCT00001032
What this trial is testing

Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 180
Early research (Phase 1)WithdrawnNCT02343666
What this trial is testing

HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection

Who this might be right for
Human Immunodeficiency Virus 1 PositiveStage I Adult Hodgkin LymphomaStage I Adult Non-Hodgkin Lymphoma+6 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02038842
What this trial is testing

Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers

Who this might be right for
HIV Infection
ANRS, Emerging Infectious Diseases 92
Testing effectiveness (Phase 2)WithdrawnNCT02462772
What this trial is testing

Safety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South Africa

Who this might be right for
Human Immunodeficiency Virus
Centre for the AIDS Programme of Research in South Africa
Not applicableStudy completedNCT06368453
What this trial is testing

Evaluate the Performance, Usability, and Result Interpretation of INSTI® HIV Self-Test

Who this might be right for
Human Immunodeficiency Virus I InfectionHuman Immunodeficiency Virus II Infection
bioLytical Laboratories 1,728
Testing effectiveness (Phase 2)Study completedNCT02471430
What this trial is testing

Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral Therapy

Who this might be right for
HIV Infection
Massachusetts General Hospital 17
Testing effectiveness (Phase 2)Study completedNCT00371592
What this trial is testing

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)

Who this might be right for
HIV InfectionsHerpesvirus 2, Human
National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Study completedNCT00000811
What this trial is testing

Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children

Who this might be right for
Bacterial InfectionsPneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 690
Testing effectiveness (Phase 2)Study completedNCT00000793
What this trial is testing

A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection

Who this might be right for
HIV InfectionsPeripheral Nervous System Disease
National Institute of Allergy and Infectious Diseases (NIAID) 240
Not applicableStudy completedNCT01050881
What this trial is testing

Notification of Donors With Positive Microbiology Markers

Who this might be right for
Human Immunodeficiency VirusHepatitis BHepatitis C+2 more
NHS Blood and Transplant 217
Testing effectiveness (Phase 2)Study completedNCT04120415
What this trial is testing

A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)

Who this might be right for
HIV-1-infection
ANRS, Emerging Infectious Diseases 2
Not applicableStudy completedNCT01347437
What this trial is testing

Improving Antiretroviral Medication Adherence Among HIV-infected Youth

Who this might be right for
HIV Infection
Fenway Community Health 17
Testing effectiveness (Phase 2)Study completedNCT00189930
What this trial is testing

An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in HIV-1 Infected Patients

Who this might be right for
HIV Infection
Bavarian Nordic 77
Testing effectiveness (Phase 2)Study completedNCT03601806
What this trial is testing

Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection

Who this might be right for
Human Immunodeficiency Virus 1 PositiveSkin Kaposi Sarcoma
AIDS Malignancy Consortium 26
Testing effectiveness (Phase 2)Study completedNCT00055341
What this trial is testing

Treatment of Hepatitis C in Hemophilic Patients With HIV

Who this might be right for
HIV InfectionsHepatitis CHemophilia
National Institute of Allergy and Infectious Diseases (NIAID) 22
Early research (Phase 1)Study completedNCT00000837
What this trial is testing

The Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 127
Testing effectiveness (Phase 2)Study completedNCT00000644
What this trial is testing

A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)Study completedNCT00799864
What this trial is testing

Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years

Who this might be right for
HIV-1
Janssen Sciences Ireland UC 54
Large-scale testing (Phase 3)Study completedNCT00860977
What this trial is testing

Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?

Who this might be right for
HIV InfectionHerpes Simplex Type IIHIV Infections
University Health Network, Toronto 202
Load More Results